Asthma - Pipeline Review, H2 2018

Global Markets Direct’s, ‘Asthma - Pipeline Review, H2 2018’, provides an overview of the Asthma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Asthma

- The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects

- The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Asthma

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Asthma

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

4D Pharma PLC

AB Science SA

AbbVie Inc

Abeome Corp

Accolade Pharmaceuticals LLC

Adamis Pharmaceuticals Corp

ALK-Abello AS

Allergan Plc

Allergopharma GmbH & Co KG ...

4D Pharma PLC

AB Science SA

AbbVie Inc

Abeome Corp

Accolade Pharmaceuticals LLC

Adamis Pharmaceuticals Corp

ALK-Abello AS

Allergan Plc

Allergopharma GmbH & Co KG

Almirall SA

Amgen Inc

Amphastar Pharmaceuticals Inc

AnaptysBio Inc

AnGes Inc

Antisense Therapeutics Ltd

Apollo Endosurgery Inc

ASIT Biotech SA

Aslan Pharmaceuticals Pte Ltd

Astellas Pharma Inc

AstraZeneca Plc

Aurigene Discovery Technologies Ltd

Biocon Ltd

BiosanaPharma BV

Biotec Pharmacon ASA

Boehringer Ingelheim GmbH

Celon Pharma SA

Chiesi Farmaceutici SpA

Crossject SA

CrystalGenomics Inc

CSL Ltd

CSPC Pharmaceutical Group Limited

Cumberland Pharmaceuticals Inc

Cynata Therapeutics Ltd

Cytokinetics Inc

Daiichi Sankyo Co Ltd

Denceptor Therapeutics Ltd

Energenesis Biomedical Co Ltd

Enterprise Therapeutics Ltd

F. Hoffmann-La Roche Ltd

FLX Bio Inc

Fountain Biopharma Inc

Genentech Inc

GeneScience Pharmaceuticals Co Ltd

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

Gossamer Bio Inc

Humanigen Inc

Hydra Biosciences Inc

iCeutica Inc

iCo Therapeutics Inc

Icure Pharmaceutical Inc

Idorsia Pharmaceutical Ltd

InKemia IUCT Group SA

Inspyr Therapeutics Inc

Intech Biopharm Ltd

Invion Ltd

JHL Biotech Inc

KBP BioSciences Co Ltd

Kissei Pharmaceutical Co Ltd

Knopp Biosciences LLC

Kyowa Hakko Kirin Co Ltd

Laboratorios LETI SL

Lead Discovery Center GmbH

LG Chem Ltd

Longevity Biotech Inc

Medicenna Therapeutics Corp

MedImmune LLC

Merck & Co Inc

Mitsubishi Tanabe Pharma Corp

Mycenax Biotech Inc

NAL Pharmaceuticals Ltd

NeoPharm Co Ltd

Novartis AG

Omeros Corp

Ono Pharmaceutical Co Ltd

OPKO Health Inc

Orbis Biosciences Inc

Orchid Pharma Ltd

Orion Corp

Oxagen Ltd

Paradigm Biopharmaceuticals Ltd

Paragen Bio Pty Ltd

Pfizer Inc

Pharmaxis Ltd

Pieris Pharmaceuticals Inc

Progenra Inc

Promedior Inc

Prommune Inc

Pulmagen Therapeutics LLP

Pulmatrix Inc

Pulmokine Inc

Pulmotect Inc

Qu Biologics Inc

Qurient Co Ltd

Re-Pharm Ltd

Regeneron Pharmaceuticals Inc

Reliance Life Sciences Pvt Ltd

Respiratorius AB

Revalesio Corp

ReveraGen BioPharma Inc

Ribomic Inc

Saje Pharma LLC

Sam-A Pharm Co Ltd

SolAeroMed Inc

sterna biologicals GmbH & Co KG

Sumitomo Dainippon Pharma Co Ltd

Sun Pharma Advanced Research Company Ltd

Swecure AB

Synermore Biologics Co Ltd

TaiwanJ Pharmaceuticals Co Ltd

Teva Pharmaceutical Industries Ltd

The Geneva Biotech Center SA

Therabron Therapeutics Inc

Theravance Biopharma Inc

Torrent Pharmaceuticals Ltd

United BioPharma Inc

Vascular BioSciences

Vectura Group Plc

Verona Pharma Plc

WhanIn Pharmaceutical Co Ltd

Xencor Inc

Yuhan Corp

Zai Lab Ltd

Table of Contents

Table of Contents

Table of Contents 2

Introduction 8

Asthma - Overview 9

Asthma - Therapeutics Development 10

Asthma - Therapeutics Assessment 38

Asthma - Companies Involved in Therapeutics ...

Table of Contents

Table of Contents 2

Introduction 8

Asthma - Overview 9

Asthma - Therapeutics Development 10

Asthma - Therapeutics Assessment 38

Asthma - Companies Involved in Therapeutics Development 54

Asthma - Drug Profiles 112

Asthma - Dormant Projects 568

Asthma - Discontinued Products 594

Asthma - Product Development Milestones 600

Appendix 612

List of Tables

List of Tables

Number of Products under Development for Asthma, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under ...

List of Tables

Number of Products under Development for Asthma, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under Development by Universities/Institutes, H2 2018

Products under Development by Companies, H2 2018

Products under Development by Universities/Institutes, H2 2018

Number of Products by Stage and Target, H2 2018

Number of Products by Stage and Mechanism of Action, H2 2018

Number of Products by Stage and Route of Administration, H2 2018

Number of Products by Stage and Molecule Type, H2 2018

Asthma - Pipeline by 4D Pharma PLC, H2 2018

Asthma - Pipeline by AB Science SA, H2 2018

Asthma - Pipeline by AbbVie Inc, H2 2018

Asthma - Pipeline by Abeome Corp, H2 2018

Asthma - Pipeline by Accolade Pharmaceuticals LLC, H2 2018

Asthma - Pipeline by Adamis Pharmaceuticals Corp, H2 2018

Asthma - Pipeline by ALK-Abello AS, H2 2018

Asthma - Pipeline by Allergan Plc, H2 2018

Asthma - Pipeline by Allergopharma GmbH & Co KG, H2 2018

Asthma - Pipeline by Almirall SA, H2 2018

Asthma - Pipeline by Amgen Inc, H2 2018

Asthma - Pipeline by Amphastar Pharmaceuticals Inc, H2 2018

Asthma - Pipeline by AnaptysBio Inc, H2 2018

Asthma - Pipeline by AnGes Inc, H2 2018

Asthma - Pipeline by Antisense Therapeutics Ltd, H2 2018

Asthma - Pipeline by Apollo Endosurgery Inc, H2 2018

Asthma - Pipeline by ASIT Biotech SA, H2 2018

Asthma - Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2018

Asthma - Pipeline by Astellas Pharma Inc, H2 2018

Asthma - Pipeline by AstraZeneca Plc, H2 2018

Asthma - Pipeline by Aurigene Discovery Technologies Ltd, H2 2018

Asthma - Pipeline by Biocon Ltd, H2 2018

Asthma - Pipeline by BiosanaPharma BV, H2 2018

Asthma - Pipeline by Biotec Pharmacon ASA, H2 2018

Asthma - Pipeline by Boehringer Ingelheim GmbH, H2 2018

Asthma - Pipeline by Celon Pharma SA, H2 2018

Asthma - Pipeline by Chiesi Farmaceutici SpA, H2 2018

Asthma - Pipeline by Crossject SA, H2 2018

Asthma - Pipeline by CrystalGenomics Inc, H2 2018

Asthma - Pipeline by CSL Ltd, H2 2018

Asthma - Pipeline by CSPC Pharmaceutical Group Limited, H2 2018

Asthma - Pipeline by Cumberland Pharmaceuticals Inc, H2 2018

Asthma - Pipeline by Cynata Therapeutics Ltd, H2 2018

Asthma - Pipeline by Cytokinetics Inc, H2 2018

Asthma - Pipeline by Daiichi Sankyo Co Ltd, H2 2018

Asthma - Pipeline by Denceptor Therapeutics Ltd, H2 2018

Asthma - Pipeline by Energenesis Biomedical Co Ltd, H2 2018

Asthma - Pipeline by Enterprise Therapeutics Ltd, H2 2018

Asthma - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018

Asthma - Pipeline by FLX Bio Inc, H2 2018

Asthma - Pipeline by Fountain Biopharma Inc, H2 2018

Asthma - Pipeline by Genentech Inc, H2 2018

Asthma - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2018

Asthma - Pipeline by GlaxoSmithKline Plc, H2 2018

Asthma - Pipeline by Glenmark Pharmaceuticals Ltd, H2 2018

Asthma - Pipeline by Gossamer Bio Inc, H2 2018

Asthma - Pipeline by Humanigen Inc, H2 2018

Asthma - Pipeline by Hydra Biosciences Inc, H2 2018

Asthma - Pipeline by iCeutica Inc, H2 2018

List of Figures

List of Figures

Number of Products under Development for Asthma, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under ...

List of Figures

Number of Products under Development for Asthma, H2 2018

Number of Products under Development by Companies, H2 2018

Number of Products under Development by Universities/Institutes, H2 2018

Number of Products by Top 10 Targets, H2 2018

Number of Products by Stage and Top 10 Targets, H2 2018

Number of Products by Top 10 Mechanism of Actions, H2 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018

Number of Products by Top 10 Routes of Administration, H2 2018

Number of Products by Stage and Top 10 Routes of Administration, H2 2018

Number of Products by Top 10 Molecule Types, H2 2018

Number of Products by Stage and Top 10 Molecule Types, H2 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports